Geovax Labs, Inc.

GeoVax Advances Gedeptin(R) Toward Phase 2 Initiation and Strategic Partnership Opportunities

GeoVax Reports 2025 Year-End Financial Results and Provides Business Update

GeoVax Positions GEO-MVA to Address Supply Constraints in Global Mpox and Smallpox Vaccine Market

GeoVax Highlights Single-Dose Mpox Vaccine Data at World Vaccine Congress 2026

GeoVax Announces a Warrant Inducement Transaction